N-α-Fmoc-N-ω-tosyl-L-arginine is a protected, proteinogenic amino acid derivative in which L-arginine is modified at both the α-amino group and the ω-guanidinium side chain, forming a bis-protected intermediate for peptide chemistry. The molecule bears an Fmoc carbamate on the α-nitrogen and a tosyl (p-toluenesulfonyl) group on the side-chain guanidinium nitrogen, while retaining the free carboxyl functional group as part of the amino acid backbone. In synthesis workflows such as stepwise peptide assembly, the orthogonal protection pattern supports controlled chemoselectivity for sequential deprotection and coupling steps, and the protected arginine side chain provides a defined handle for incorporation into larger peptide structures under conditions that avoid side-chain guanidinium reactivity.
CAT No: CP00225
CAS No:83792-47-6
Synonyms/Alias:Fmoc-Arg(Tos)-OH;83792-47-6;Nalpha-Fmoc-Nomega-tosyl-L-arginine;C28H30N4O6S;Argininederivative6;PubChem18947;AC1MHS92;47534_ALDRICH;SCHEMBL119376;BDBM9853;CHEMBL427133;47534_FLUKA;MolPort-003-934-154;ACT10918;ZINC4544657;CF-166;AKOS015895653;AKOS015922867;AK-81179;K495;F0883;FT-0641922;ST24047231;ST51052917;Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Nomega-tosyl-L-arginine
N-α-Fmoc-N-ω-tosyl-L-arginine is an Fmoc-protected, side-chain-protected L-arginine derivative that retains the stereogenic α-carbon of L-arginine while masking the guanidinium functionality as an ω-tosyl-protected amidine/guanidine equivalent. The molecule combines an N-terminal fluorenylmethoxycarbonyl (Fmoc) carbamate with a tosyl group on the side-chain nitrogen(s), creating orthogonal protection elements that support controlled deprotection during peptide assembly. The presence of the carboxylate as a free acid and the protected guanidine-like functionality yields a defined reactivity profile: Fmoc can be removed under base without directly exposing the side-chain charge, while the tosyl group can be removed later to regenerate the strongly basic arginine side chain. This protected amino acid is therefore suited to peptide building-block synthesis, fragment derivatization, and downstream conversion to arginine-containing motifs used in biochemical research and industrial peptide manufacturing.
1. Peptide Synthesis
N-α-Fmoc-N-ω-tosyl-L-arginine is used in solid-phase and solution-phase peptide synthesis workflows where orthogonally protected arginine side chains are required. The Fmoc carbamate enables iterative N-terminal coupling after base-mediated Fmoc removal, while the ω-tosyl group suppresses side-chain guanidinium reactivity during coupling cycles. The free α-carboxylic acid participates in standard peptide coupling chemistry to form amide bonds with incoming amino components, supporting incorporation into Arg-rich sequences and controlled generation of cationic residues after final deprotection. The resulting peptide products can be used as reference standards, mechanistic probes, or precursor materials for larger biomolecular constructs, aligning the protected arginine chemistry with established peptide science practices.
2. Chemical Biology Probes
N-α-Fmoc-N-ω-tosyl-L-arginine is applied in chemical biology for preparing arginine-containing peptide probes that require delayed exposure of the guanidinium functionality. The tosyl-protected side chain helps maintain low side-reaction propensity during assembly of labeled or modified peptide scaffolds, including constructs that later undergo guanidine deprotection to restore strong ionic interactions for binding studies. The Fmoc handle supports synthesis of well-defined N-termini, which can be further functionalized for affinity capture, uptake assays, or receptor-interaction mapping. The downstream arginine regeneration supports electrostatic recognition features typical of protein interfaces and nucleic-acid binding motifs, enabling structured amino acid chemistry to translate into controllable molecular recognition reagents.
3. Bioconjugation Chemistry
N-α-Fmoc-N-ω-tosyl-L-arginine is suitable for bioconjugation-oriented intermediate preparation where arginine side-chain protection is needed to manage reactivity during coupling to biomolecules. The protected guanidine-like group minimizes undesired crosslinking and side reactions when generating peptide linkers, cell-penetrating segments, or affinity tags that are later conjugated to proteins, polymers, or nanoparticles. The Fmoc-protected α-amino group supports stepwise construction of conjugation-ready peptides with defined attachment points, while the orthogonal tosyl protection allows staged deprotection to tune charge state and conjugation behavior. The resulting conjugation intermediates can feed into downstream labeling strategies and biomolecule modification workflows that rely on controlled presentation of cationic arginine residues.
4. Pharmaceutical Manufacturing
N-α-Fmoc-N-ω-tosyl-L-arginine is relevant to pharmaceutical manufacturing of peptide-based intermediates and process-scale synthesis of arginine-containing drug candidates or excipients. The dual protection pattern, Fmoc on the backbone nitrogen and tosyl on the side chain, supports predictable deprotection sequencing and reduces the likelihood of premature side-chain activation during manufacturing steps. The free carboxylic acid and protected amine enable incorporation into peptide sequences using coupling chemistries compatible with industrial peptide production, supporting reproducible formation of amide linkages. The compound can serve as a controlled chiral building block for generating defined peptide fragments that later undergo final global deprotection and purification, aligning protected amino acid chemistry with scalable fine chemical production.
5. Process Chemistry Intermediate
N-α-Fmoc-N-ω-tosyl-L-arginine is utilized as a process chemistry intermediate for producing protected arginine derivatives and for designing manufacturing routes that require orthogonal protection control. The Fmoc group provides a base-labile protecting strategy for the α-amino functionality, while the ω-tosyl group offers a distinct protection level for the side-chain guanidine equivalent, enabling staged transformations without changing the L-configuration at the α-carbon. The protected functional groups help manage solubility and reactivity during isolation and purification steps, supporting consistent handling in synthetic operations. The chiral amino acid intermediate nature of the compound also enables downstream derivatization into alternative protected arginine formats or peptide building blocks used across specialty chemical production and industrial peptide synthesis.
6. Analytical Reference Standards
N-α-Fmoc-N-ω-tosyl-L-arginine is suitable for analytical research and method development where protected arginine species serve as reference materials for monitoring peptide synthesis and deprotection performance. The combination of Fmoc chromophore and tosyl-protected side chain generates a defined set of physicochemical and spectroscopic signatures that can be tracked by chromatographic and mass-based workflows. The preserved L-stereochemistry and stable protecting groups support reproducible identification of intermediates, including verification of coupling completion, monitoring of side-chain protection integrity, and confirmation of deprotection endpoints in arginine-containing sequences. The compound's structure-function relationship supports its use as a calibration or qualification component for quality control in peptide chemistry and amino acid derivatization studies.
2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.